FDA Finds Another Carcinogen in Certain Valsartan Heart Meds
FRIDAY, Sept. 14, 2018 -- The U.S. Food and Drug Administration warns that it has found a second impurity in three lots of Torrent Pharmaceuticals ' valsartan drug products.
The FDA first recalled valsartan medicines back in July, after the Chinese...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Cardiology | China Health | Diovan | Food and Drug Administration (FDA) | Heart | Pharmaceuticals